Navigation Links
Mount Sinai Selects Exemplar LIMS for Genomics Core Facility
Date:5/1/2013

BALTIMORE, May 1, 2013 /PRNewswire/ -- Exemplar LIMS™ has been selected as the lab management solution for the Genomics Core Facility at The Mount Sinai Medical Center in New York.  Sapio's LIMS system will track multiple next-generation sequencing (NGS) platform workflows from request through secondary analysis.

The Mount Sinai Genomics Core Facility is a CLIA-certified laboratory, and Exemplar LIMS is used to perform the detailed tracking required for NGS clinical sample processing.  The Exemplar LIMS system enables the Mount Sinai user community to submit samples online and track the sequencing process.  Also, Exemplar LIMS offers automatic initiation of primary analysis at the end of the sequencing process and provides frequent progress updates to users.  Exemplar also generates billing information that is passed onto the Mount Sinai financial system.

"Mount Sinai is a world leader in the genomics domain at the forefront of NGS research, with one of the few labs certified for processing clinical NGS samples in the US," said Kevin Cramer , VP at Sapio Sciences. "We look forward to working with the Mount Sinai team to streamline their lab operations while tracking the complete NGS pipeline."

"We selected Exemplar LIMS as it is modular in structure and configurable to expand and adapt with rapidly changing NGS and other genomic technologies," said Milind Mahajan , Ph.D., Director of the Genomics Core Facility at Mount Sinai. "Exemplar supports our CLIA sequencing and cutting-edge biological research to develop multi-scale models of disease."

Mount Sinai will also utilize Exemplar's Materials Management capability for reagent usage tracking.  Sapio's LIMS software will be deployed on Apple iPads™ using Exemplar LIMS for Tablets solution.  This enables lab technicians to take the LIMS with them as they move around the laboratory improving LIMS usability and lab technician efficiency.

For more information or to schedule a product demonstration, visit http://www.SapioSciences.com.

About Sapio Sciences Llc

Sapio Sciences is a leading provider of LIMS and Data Management software, enabling scientists to manage samples, protocols, assay data and clinical trials.  With extensive expertise in genomics/NGS labs, Exemplar LIMS breaks new ground in its breadth of functionality and ease of configuration.  With built-in Sample Management, Electronic Lab Notebook (ELN), scientific data management (SDMS) and integrated analytics, Exemplar LIMS addresses the full life cycle of samples from receipt to processing and analysis.  Sapio will continue to lead in ease of use and breadth of functionality across its product line, enabling organizations to reduce costs while increasing productivity and efficiency of both laboratories and researchers alike.  


'/>"/>
SOURCE Sapio Sciences Llc
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. The right amount of vitamin D for babies
2. Mount Sinai study identifies new gene variations associated with heart rate
3. Mount Sinai leads global program using stem cells to accelerate cures for Alzheimers disease
4. Intermountain study finds length of DNA strands can predict life expectancy
5. Antibacterial agent used in common soaps found in increasing amounts in freshwater lakes
6. Evidence mounts for role of mutated genes in development of schizophrenia
7. Mount Sinai grad student, 25, named to Forbes 30 Under 30 in Science and Healthcare
8. New book details the biological and cultural diversity of Khawa Karpo, sacred mountain of Tibet
9. MARC travel awards announced for the 2012 ISCB Rocky Mountain Bioinformatics Conference
10. From Mediterranean coasts to Tatra Mountains and beyond: Plant chromosome number variation
11. Mini-pig tale provides massive amount of genomic data for human health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... August 25, 2020 , ... ... novel pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical company ... U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic solution in patients with ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien ... announced that the U.S. Food and Drug Administration (FDA) has approved the company’s ... for the treatment of severe COVID-19. Approval of this IND allows Sentien to ...
(Date:8/12/2020)... SOUTHFIELD, Mich. (PRWEB) , ... August 11, 2020 ... ... Janssen R&D subsidiary based in Princeton, NJ, have entered into license agreements with ... discovery and development. Both Roche and J&J have annual Research and Development ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... engineering firm, is making available for free its new white paper – ... transport simulation testing into today’s biologics licensing application (BLA). In response, Modality ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – ... , Known as MediVet Biologics since its formation in 2016, ... The new Ardent Animal Health will build on its base of innovative therapies for ...
(Date:7/31/2020)... ... 2020 , ... Anomet Products has introduced new custom composite ... with CRM, neurostimulation, vascular, and related devices. , Anomet Medical Clad Wire ... and cost criteria; especially where solid wire is limited. Typical configurations for implantable ...
(Date:7/31/2020)... (PRWEB) , ... July 30, ... ... of cloud-based software for the life sciences industry, today announced the release ... platform designed specifically for Medical Science Liaisons (MSLs) and other field medical ...
Breaking Biology Technology: